peptides typeshitSafety
The Times hears from women who got pregnant while taking Mounjaro
One writer shares her own unexpected pregnancy while taking the tirzepatide shot, and says many others have been through the same thing.
peptides
-
The Times hears from women who got pregnant while taking Mounjaro -
Experimental injection that makes fat cells self destruct shows early promise 
Experimental injection that makes fat cells self destruct shows early promise
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
-
Philstar Life on semaglutide and the PIONEER 8 trial peptides typeshitResearchPhilstar Life on semaglutide and the PIONEER 8 trial
A short Philstar Life item on PIONEER 8, a trial of oral semaglutide. The material gives only the title, so tap through for the details.
-
Mochi Health cuts prices on compounded semaglutide and tirzepatide 
Mochi Health cuts prices on compounded semaglutide and tirzepatide
The telehealth company is also adding blood testing services alongside the lower costs for its compounded GLP-1 options.
-
Andrew Huberman on certified USA made peptides and verified standards 
Andrew Huberman on certified USA made peptides and verified standards
Huberman says verified, US-made sourcing would change the peptide market, and wonders which compounds beyond GLPs would qualify.
-
IOHA explains why burning stored body fat is harder than it seems IOHA explains why burning stored body fat is harder than it seems
A general explainer on why the body holds onto its large fat reserves even though they carry tens of thousands of calories.
-
Dr Aryanna Amini cautions against comparing two separate retatrutide studies 
peptides typeshitResearchDr Aryanna Amini cautions against comparing two separate retatrutide studies
She points out one trial enrolled people with diabetes and the other excluded them, so the results aren't a head to head match.
-
Medik8 pairs Liquid Peptides Advanced MP with Crystal Retinal for nights 
Medik8 pairs Liquid Peptides Advanced MP with Crystal Retinal for nights
The skincare brand suggests applying its peptide serum first for hydration, then retinal at night for anti-ageing.
-
International Myeloma Foundation looks at GLP-1 drug safety for myeloma patients International Myeloma Foundation looks at GLP-1 drug safety for myeloma patients
The IMF addresses whether GLP-1 weight loss medications are a safe option for people with myeloma, including those with insulin resistance.
-
Roseland Lashay shares her maintenance meals after losing 60 lbs on tirzepatide 
26:51
Roseland Lashay shares her maintenance meals after losing 60 lbs on tirzepatide
A full day of low carb, high protein eating from Roseland Lashay as she shifts into maintenance on tirzepatide.
-
Samuel Hume lists three big psoriasis drug advances, including tirzepatide Samuel Hume lists three big psoriasis drug advances, including tirzepatide
Icotrokinra became the first approved oral IL23 receptor blocker, and a trial found tirzepatide plus ixekizumab gave deeper responses.
-
Oral Wegovy scripts dip 3.3% while Zepbound keeps a wide lead over Novo Oral Wegovy scripts dip 3.3% while Zepbound keeps a wide lead over Novo
Oral Wegovy fell to about 173,500 weekly prescriptions and Foundayo rose to 60,151. Novo also eyes 15 to 20% yearly GLP-1 growth in India.
-
Dr Almerie looks at what retatrutide may do beyond weight loss 
9:11
Dr Almerie looks at what retatrutide may do beyond weight loss
Physician Dr Almerie talks through retatrutide and the effects it may have past the number on the scale.
-
Fitwithliz shares a day of eating on Wegovy after dropping 50 lbs 
11:28
Fitwithliz shares a day of eating on Wegovy after dropping 50 lbs
Liz cooks her meals for the day, runs through her skincare and catches viewers up on life 50 lbs into Wegovy.
-
USA TODAY says much of the podcast talk about experimental peptides is misleading USA TODAY says much of the podcast talk about experimental peptides is misleading
Peptides have become a favorite of longevity and optimization podcasts, and USA TODAY looks at where those claims go wrong.
-
HighFold-Lasso extends AlphaFold3 to predict lasso peptide structures peptides typeshitResearchHighFold-Lasso extends AlphaFold3 to predict lasso peptide structures
Researchers built a topology-guided add-on to AlphaFold3 aimed at the threaded tail that trips up lasso peptide structure prediction.
-
Dr Bazgha Khalid explains retatrutide, the weight loss drug still in trials 
8:28
peptides typeshitResearchDr Bazgha Khalid explains retatrutide, the weight loss drug still in trials
A weight loss doctor walks through retatrutide, which she calls the most anticipated obesity drug currently in clinical trials.
-
Allegheny County starts $13.3M trial of Ozempic for opioid and alcohol addiction 
Allegheny County starts $13.3M trial of Ozempic for opioid and alcohol addiction
The Pennsylvania county is funding a study into whether the GLP-1 drug can help people with substance use disorders.
-
KFF Health News looks at misleading peptide claims on longevity podcasts 
KFF Health News looks at misleading peptide claims on longevity podcasts
Amy Maxmen reports on how experimental peptides are being hyped in optimization circles and where the talk goes wrong.
-
A man on what Ozempic did for his compulsive eating, and what came after 
A man on what Ozempic did for his compulsive eating, and what came after
A personal story about the control he felt on the drug and the cravings for it that followed once he stopped.
-
EU medicines committee recommends Lilly's Foundayo pill for obesity and diabetes 
EU medicines committee recommends Lilly's Foundayo pill for obesity and diabetes
The CHMP opinion from 15 October now goes to the European Commission. In trials, people on the daily orforglipron tablet lost about 5% to 11% of body weight over 72 weeks.
-
Patent histories of 25 gray-market peptides show deep ties to big pharma Patent histories of 25 gray-market peptides show deep ties to big pharma
Dr David Barzilai traced the development records of popular compounds and found many trace back to pharmaceutical companies.
-
Bahrain's NHRA approves Wegovy pills for treating obesity 
Bahrain's NHRA approves Wegovy pills for treating obesity
The country's health regulator has cleared the oral version of Novo Nordisk's semaglutide for weight management.
-
Mochi Health moves to dose-based GLP-1 pricing and launches Mochi Labs bloodwork Mochi Health moves to dose-based GLP-1 pricing and launches Mochi Labs bloodwork
Compounded semaglutide and tirzepatide now cost less at lower starting doses, and members can order cholesterol, A1C and thyroid panels in the same app.
-
Mochi Health cuts compounded semaglutide and tirzepatide prices, adds lab testing Mochi Health cuts compounded semaglutide and tirzepatide prices, adds lab testing
Pricing now scales with dose, so people on lower starting doses pay less. The new Mochi Labs bloodwork service tracks A1C, cholesterol and thyroid, though not in NY, NJ, RI or HI.
-
Investor breaks down Hims & Hers stock after a 56% drop and its GLP-1 pivot Investor breaks down Hims & Hers stock after a 56% drop and its GLP-1 pivot
Inversor Bético rates the business strongly but says entry timing isn't there yet, pointing to margins squeezed by the move from compounded to branded GLP-1s.
-
Bahrain's NHRA approves Wegovy pills, oral semaglutide for obesity 
Bahrain's NHRA approves Wegovy pills, oral semaglutide for obesity
Bahrain's National Health Regulatory Authority signed off on the oral GLP-1 version of Wegovy for treating obesity, per the state news agency.
-
Eli Lilly posts $22.97B quarter and plans a retatrutide FDA filing in early 2027 
Eli Lilly posts $22.97B quarter and plans a retatrutide FDA filing in early 2027
Revenue rose 48% on Mounjaro and Zepbound demand, and Lilly raised 2026 guidance to $85B to $87B. CEO David Ricks calls retatrutide the next growth driver.
-
Peptide compounders face growing USP 795 and 797 scrutiny from regulators 
Peptide compounders face growing USP 795 and 797 scrutiny from regulators
A pharmacy attorney explains why boards and plaintiffs now treat USP standards as the baseline, and why research use only labels won't shield sloppy compounding.
-
Dr Sheth pairs copper peptides with retinol for firmer skin and a stronger barrier 
Dr Sheth pairs copper peptides with retinol for firmer skin and a stronger barrier
Retinol speeds up cell turnover while copper peptides back skin repair and collagen and elastin production. A short skincare explainer on using both.
